Skip to content

Brain Research Bulletin

ISSN 1873-2747, 0361-9230

42 papers in the library · 674 citations · publishing 1977-2026

Papers

Sort Most recent Most cited

Multiband ALFF in patients with major depressive disorder treated with esketamine and sertraline: A preliminary study

Brain Research Bulletin October 6, 2026 Ziyi Hua, Yongqiang Shu, Li Li et al.

INTRODUCTION: This study investigated changes in multiband amplitude of low-frequency fluctuations in patients with major depressive disorder following a 2-week combination treatment regimen of esketamine and sertraline, and examined the associations between ALFF changes and clinical symptom improvement. METHODS: Forty patients with major depressive disorder (MDD) received esketamine (0.25...

Esketamine alleviates trigeminal neuralgia and anxiety-like behaviors in mice by inhibiting RIPK1/RIPK3/MLKL-mediated necroptosis.

Brain Research Bulletin August 1, 2026 Rui Dong, Jiaxin Liu, Yumei Shen et al.

Trigeminal neuralgia (TN) is a debilitating orofacial pain condition frequently complicated by anxiety and depression, forming a self-reinforcing pain-affect cycle with limited therapeutic options. A TN mouse model with anxiety-like behavior was established using partial infraorbital nerve transection (pIONT). Esketamine (ES) (5 or 10 mg/kg) was administered intraperitoneally from postoperative...

Chronic THC exposure modulates behavioral outcomes and endocannabinoid signaling in HIV-1 Tg26 mice in a sex-dependent manner.

Brain Research Bulletin August 1, 2026 Barkha J. Yadav-Samudrala, Laith E. Sawaqed, Caitlin J. Huguely Wilkinson et al.

While combined antiretroviral therapy (cART) has transitioned HIV-1 into a manageable chronic condition, it fails to eradicate latent viral reservoirs in the central nervous system (CNS) that drive persistent neuroinflammation and synaptodendritic injury. Consequently, people living with human immunodeficiency virus type-1 (HIV-1) often utilize cannabis to manage neurological symptoms, yet the...

Shared neural mechanisms of trait mindfulness and hypnotic susceptibility: A scoping review toward a unifying predictive coding framework.

Brain Research Bulletin June 27, 2026 Qiang Chen, Yating Zhang, Chenrui Liu et al.

This scoping review systematically compares the neural mechanisms underlying trait mindfulness and hypnosis susceptibility, focusing on three key dimensions: brain region activation, electroencephalographic (EEG) signals, and core brain networks. The aim is to elucidate potential shared mechanisms involved in conscious state modulation. Through a comprehensive review of existing brain imaging...

Ketamine-induced changes in accumbal glutamate and their association with altered states of consciousness.

Brain Research Bulletin May 1, 2026 Ladina Philomena Gubser, Anna Stefania Trippel, Niklaus Zoelch et al.

Ketamine has been shown to modulate glutamate signaling in animals and may therefore have the potential to restore glutamate imbalances in the brain. Impaired glutamate homeostasis has been implicated in mental health disorders such as substance use disorders (SUDs). Thus, we investigated ketamine's potential to increase glutamate levels in the nucleus accumbens (NAc), a key region for the...

Prefrontal Neurophysiological Changes Associated with Subanesthetic Esketamine Accelerating Mice Emergence from Propofol Anesthesia.

Brain Research Bulletin November 22, 2025 Yinying Sun, Bo Li, Yiting Wang et al.

Recent studies have demonstrated that subanesthetic dose of ketamine or its S-enantiomer, esketamine, can paradoxically accelerate the recovery of consciousness in rodents following general anesthesia. However, the neural mechanisms underlying this "awakening-promoting" effect remain poorly understood. Adult C57BL/6J mice were anesthetized with propofol, 0and a low dose of esketamine (2mg/kg)...

DOI: 10.1016/j.brainresbull.2025.111648 (opens in new tab) Full text (opens in new tab) Calcium imaging Neurotransmitter dynamics Paradoxical emergence Prefrontal cortex +6

Esketamine combined with sertraline for brain altered regional homogeneity in patients with major depressive disorder: A preliminary study.

Brain Research Bulletin November 13, 2025 Xiang Liu, Ziyi Hua, Yongqiang Shu et al. 1 citation

This study aims to explore the relationship between the antidepressant effects of drugs (esketamine combined with sertraline) and brain function changes in patients with major depressive disorder. A total of 27 patients with major depressive disorder (MDD) and 27 healthy individuals were included in the study. All MDD patients received a 2-week course of intravenous esketamine infusion (0.25...

Esketamine relieves depressive-like behaviors in MPTP-induced Parkinson disease mice via GPR109A-dependent reduction of neuroinflammation

Brain Research Bulletin October 27, 2025 Shu Wang, Wei Song, Yuanyuan Gao et al.

Background: Depression is a common complication of Parkinson disease (PD). This study investigated whether a single dose of esketamine could alleviate depressive symptoms in an MPTP mouse model by activating G protein-coupled receptor 109 A (GPR109A) and reducing neuroinflammation. Methods: Adult male C57BL/6 J mice (8 weeks, 25–30 g) were allocated into three groups: saline,...

Meditation attenuates default-mode activity: A pilot study using ultra-high field 7 Tesla MRI.

Brain Research Bulletin October 15, 2023 Saampras Ganesan, Bradford A. Moffat, Nicholas T. van Dam et al. 13 citations

Mapping the neurobiology of meditation has been bolstered by functional MRI (fMRI) research, with advancements in ultra-high field 7 Tesla fMRI further enhancing signal quality and neuroanatomical resolution. Here, we utilize 7 Tesla fMRI to examine the neural substrates of meditation and replicate existing widespread findings, after accounting for relevant physiological confounds. In this...

Subcortical control of the default mode network: Role of the basal forebrain and implications for neuropsychiatric disorders

Brain Research Bulletin May 1, 2022 David D. Aguilar, J. McNally

The precise interplay between large-scale functional neural systems throughout the brain is essential for performance of cognitive processes. In this review we focus on the default mode network (DMN), one such functional network that is active during periods of quiet wakefulness and believed to be involved in introspection and planning. Abnormalities in DMN functional connectivity and...

Brain Research Bulletin Special Issue: Brain-body communication in health and diseases Brain-spleen axis in health and diseases: a review and future perspective.

Brain Research Bulletin February 1, 2022 Yan Wei, Tong Wang, Lei Liao et al.

The spleen, an important tissue for the immune system, acts as a filter for blood within the immune system. Accumulating evidence suggests that the spleen affects a number of brain functions in health and diseases via immune modulation. Systemic inflammation or chronic social defeat stress (CSDS) can cause splenomegaly in rodents. Interestingly, the new antidepressant arketamine could normalize...

Prevention and reversal of ketamine-induced experimental psychosis in mice by the neuroactive flavonoid, hesperidin: the role of oxidative and cholinergic mechanisms.

Brain Research Bulletin October 1, 2021 I. Ishola, Benneth Ben-Azu, Oluwatosin A. Adebayo et al.

Currently, prevailing evidence have identified cholinergic and oxidative pathways as important therapeutic targets for abating ketamine-induced schizophrenia-like behavior. Thus, this study evaluated the ability of hesperidin, a naturally occurring antioxidant and neuroprotective flavonoid, to prevent and reverse ketamine-induced schizophrenia-like behaviors and changes in cholinergic,...

Ketamine reversed short-term memory impairment and depressive-like behavior in animal model of Parkinson's disease.

Brain Research Bulletin December 22, 2020 D. D. Vecchia, L. Kanazawa, E. Wendler et al.

The most common features of Parkinson's disease (PD) are motor impairments, but many patients also present depression and memory impairment. Ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, has been shown to be effective in patients with treatment-resistant major depression. Thus, the present study evaluated the action of ketamine on memory impairment and depressive-like behavior...

Essential roles of neuropeptide VGF regulated TrkB/mTOR/BICC1 signaling and phosphorylation of AMPA receptor subunit GluA1 in the rapid antidepressant-like actions of ketamine in mice.

Brain Research Bulletin October 2018 Mengxin Shen, Dan Lv, Xu Liu et al.

Previous studies have suggested that rapid reductions in depression-like behaviors are observed in response to sub-anesthetic-doses of ketamine, an N-methyl-d-aspartate receptor (NMDAR) antagonist. Neuropeptide VGF (non-acronymic) is a critical effector of depression-like behaviors and is thought to be involved in the antidepressant actions of ketamine that have been demonstrated. However, the...

Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB.

Brain Research Bulletin March 1, 2018 The-Vinh Tran, Se Jin Park, Eun-Joo Shin et al.

Accumulating evidence suggests that neuroinflammation is one of the important etiologic factors of abusive and neuropsychiatric disorders. Platelet-activating factor (PAF) is potent proinflammatory lipid mediat1or and plays a pivotal role in neuroinflammatory disorders through the specific PAF receptor (PAF-R). Phencyclidine (PCP) induces a psychotomimetic state that closely resembles...

DOI: 10.1016/j.brainresbull.2017.11.004 (opens in new tab) Full text (opens in new tab) Phencyclidine Platelet-activating factor receptor Schizophrenia

Protective effect of Lycium Barbarum polysaccharides on dextromethorphan-induced mood impairment and neurogenesis suppression.

Brain Research Bulletin September 1, 2017 Kevin Kai-Ting Po, Joseph Wai-Hin Leung, Jackie Ngai-Man Chan et al.

Dextromethorphan (DXM) is one of the common drugs abused by adolescents. It is the active ingredient found in cough medicine which is used for suppressing cough. High dosage of DXM can induce euphoria, dissociative effects and even hallucinations. Chronic use of DXM may also lead to depressive-related symptoms. Lycium barbarum, commonly known as wolfberry, has been used as a traditional Chinese...

NMDA receptor adjusted co-administration of ecstasy and cannabinoid receptor-1 agonist in the amygdala via stimulation of BDNF/Trk-B/CREB pathway in adult male rats.

Brain Research Bulletin April 2017 Ghorbangol Ashabi, Mitra-Sadat Sadat-Shirazi, Solmaz Khalifeh et al.

Consumption of cannabinoid receptor-1 (CB-1) agonist such as cannabis is widely taken in 3,4- methylenedioxymethamphetamine (MDMA) or ecstasy users; it has been hypothesized that co-consumption of CB-1 agonist might protect neurons against MDMA toxicity. N-methyl-d-aspartate (NMDA) receptors regulate neuronal plasticity and firing rate in the brain through Tyrosine-kinase B (Trk-B) activation....

Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat

Brain Research Bulletin May 4, 2016 Rachel R. Horsley, Eva Lhotková, Kateřina Hájková et al. 38 citations

Methoxetamine (MXE) is a novel psychoactive compound (NPS) that emerged in 2010 as a substitute for the dissociative anaesthetic ketamine. MXE has a reputation of carrying a lower risk of harm than ketamine, however a number of deaths have been reported. Currently very little is known about the psychopharmacological effects of this compound or its toxicity; therefore we tested, in Wistar rats,...

Neuropharmacology of N,N-dimethyltryptamine

Brain Research Bulletin April 30, 2016 Theresa M. Carbonaro, Michael B. Gatch 258 citations

N,N-dimethyltryptamine (DMT) is an indole alkaloid widely found in plants and animals. It is best known for producing brief and intense psychedelic effects when ingested. Increasing evidence suggests that endogenous DMT plays important roles for a number of processes in the periphery and central nervous system, and may act as a neurotransmitter. This paper reviews the current literature of both...

DOI: 10.1016/j.brainresbull.2016.04.016 (opens in new tab) Full text (opens in new tab) Neuropharmacology Central nervous system Neurotransmitter systems Adverse effect +6

Ayahuasca: Pharmacology, neuroscience and therapeutic potential

Brain Research Bulletin March 11, 2016 Elisabet Domínguez‐clavé, Joaquim Soler, Matilde Elices et al. 220 citations

Ayahuasca is the Quechua name for a tea obtained from the vine Banisteriopsis caapi, and used for ritual purposes by the indigenous populations of the Amazon. The use of a variation of the tea that combines B. caapi with the leaves of the shrub Psychotria viridis has experienced unprecedented expansion worldwide for its psychotropic properties. This preparation contains the psychedelic 5-HT2A...

Behavioral alterations and pro-oxidant effect of a single ketamine administration to mice.

Brain Research Bulletin August 30, 2010 Francisca Charliane Carlos Da Silva, Maria Do Carmo de Oliveira Cito, Maria Izabel Gomes Da Silva et al.

A growing body of evidence has pointed to the ionotropic glutamate N-methyl-d-aspartate receptor (NMDA) as an important player in the etiology of psychopathologies, including anxiety and major depression. Clinical findings suggest that ketamine may be used for the treatment of major depression. There is evidence that reactive oxygen species also play an important role in the pathogenesis of...

Neural correlates of focused attention and cognitive monitoring in meditation.

Brain Research Bulletin April 29, 2010 Antonietta Manna, Antonino Raffone, Mauro Gianni Perrucci et al.

Meditation refers to a family of complex emotional and attentional regulatory practices, which can be classified into two main styles - focused attention (FA) and open monitoring (OM) - involving different attentional, cognitive monitoring and awareness processes. In a functional magnetic resonance study we originally characterized and contrasted FA and OM meditation forms within the same...